221/399Câncer
Campos FC, Panis C, Rossi T, Victorino VJ, Cecchini AL, Cecchini R. Aspects related to oxidative stress-mediated toxicity of doxorubicin during chemotherapy treatment. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.1, p. 21-5, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2012;32(1)p.21-5.pdf

HEMOTERAPIA; DOXORUBICIN; ESTRESS OXIDANTE; EFEITOS TARDIOS; TOXICIDADE

222/399US=42 / Gastro
Ghaneh P, Neoptolemos JP. Adjuvant chemotherapy in pancreatic cancer. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 741-8. ISBN 978-1-4051-4664-7.

CANCER DE PANCREAS; QUIMIOTERAPIA ADJUVANTE; QUIMIORADIOTERAPIA

223/399US=42 / Gastro
Chua YJ, Cunningham D. Palliative chemotherapy for advanced pancreatic cancer. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 749-56. ISBN 978-1-4051-4664-7.

CANCER DE PANCREAS AVANCADO; QUIMIOTERAPIA PALIATIVA; GEMCITABINA

224/399US=47 / Câncer
Kang J, Yu H. Targeting the spindle checkpoint in cancer chemotherapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 227-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

SEGMENTACAO DO CHECKPOINT MITOTICO; QUIMIOTERAPIA; MITOSE; SEGREGACAO DOS CROMOSSOMOS; CHECKPOINT MITOTICO; ANEUPLOIDIA; ANAFASE; UBIQUITINACAO; ANTIMITOTICOS; MAD2; CDC20; BUB1

225/399US=56 / Biol/Mol
Brower SL, Fensterer JE, Bush JE. The chemoFx assay: an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 57-78. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

ENSAIO CHEMOFX; ENSAIO EX VIVO; QUIMIOSENSIBILIDADE; QUIMIOTERAPIA; QUIMIOSSENSIBILIDADE E RESISTENCIA; CULTURA DE TECIDO PRIMARIO; MEDICINA PERSONALIZADA; CANCER

226/399US=60 / Enfermagem
Dougherty L, Bailey C. Chemotherapy. In: Corner J, Bailey C. Cancer nursing: care in context. 2nd ed. St. Louis: Blackwell Science, 2008. p. 267-316. ISBN 978-1-4051-2253-5.

CANCER; QUIMIOTERAPIA; CICLO CELULAR; CRESCIMENTO DO TUMOR; FARMACOLOGIA; DROGAS CITOTOXICAS; VIAS DE ADMINISTRACAO; QUIMIOTERAPIA AMBULATORIAL INFUSIONAL; AGENTES ANTI-CANCERIGENOS

227/399US=44 / Gastro
Jatoi A. Esophageal adenocarcinoma: chemotherapy for metastatic cancer of the esophagus, gastroesophageal junction, and stomach. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 65-7. ISBN 978-1-4051-2783-7.

CANCER DE ESOFAGO; ADENOCARCINOMA ESOFAGICO. QUIMIOTERAPIA; CANCER METASTATICO DO ESOFAGO; JUNCAO GASTROESOFAGICA; JUNCAO DO ESTOMAGO

228/399US=84 / Biol/Mol
Lan HY. TGF-B in inflammation and fibrosis: the role of TGF-B in radiation chemotherapy induced pulmonary fibrosis: inhibition of TGF-B as a novel therapeutic strategy. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 629-47. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

DESENVOLVIMENTO PULMONAR; DISPLASIA BRONCOPULMONAR; FIBROSE; ENFISEMA

229/399US=439 / Tese/FAP
Formiga MNC. Estudo do valor prognóstico da resposta precoce pelo 18FDG-PET-CT em pacientes com câncer colorretal metastático em quimioterapia de primeira linha combinada a anticorpo monoclonal. [Study of the prognostic value of early response by 18 FDG-PET-CT in patients with metastatic colorectal cancer in first line chemotherapy combined with monoclonal antibody]. São Paulo, 2012. 81 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/MariaNirvanaFormiga/MariaNirvanaFormiga.pdf

Curriculum Lattes

TOMOGRAFIA POR EMISSAO DE POSITRONS; NEOPLASIAS COLORRETAIS; ANTICORPO MONOCLONAL; QUIMIOTERAPIA; PROGNOSTICO

230/399US=1 / Quimioterapia
Brown D, Humble A. Cellular mechanisms of chemotherapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 1-17. ISBN 978-1-890504-68-7.

MECANISMOS CELULARES DE QUIMIOTERAPIA; CRESCIMENTO DE CELULAS NORMAIS E MALIGNAS; TRANSFORMACAO CELULAR

231/399US=1 / Quimioterapia
Gaddis JS, Gullatte MM. Pharmacologic principles of chemotherapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 19-37. ISBN 978-1-890504-68-7.

FARMACOLOGICOS DE QUIMIOTERAPIA; CICLO CELULAR DE RESPOSTA QUIMIOTERAPIA; AGENTES ANTINEOPLASICOS; AGENTES ALQUILANTES; TOXICIDADE DOS AGENTES ALQUILANTES; ANTIMETABOLITOS; TOXICIDADE ANTIMETABOLITO; ANTIBIOTICOS ANTITUMORAIS; FACTORES DE CRESCIMENTO HEMATOPOIETICOS; HORMONIOS; ALCALOIDES DE PLANTAS; TERAPIAS-ALVO MOLECULAR; ANTICORPOS MONOCLONAIS

232/399US=1 / Quimioterapia
Polovich M, Gullatte MM. Principles and standards of chemotherapy administration. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 39-56. ISBN 978-1-890504-68-7.

ADMINISTRACAO DE QUIMIOTERAPIA; ANTINEOPLASICO DE AGENTES CITOTOXICOS; ANTINEOPLASICA; CITOTOXICA; EQUIPAMENTOS DE PROTECAO INDIVIDUAL; PREPARACAO DE QUIMIOTERAPIA; ERROS DE QUIMIOTERAPIA. PREVENCAO; ELIMINACAO DE QUIMIOTERAPIA; ADMINISTRACAO DA DROGA VESICANTE; AGENTES QUIMIOTERAPICOS DE PROTECAO

233/399US=1 / Quimioterapia
Esper P. Targeted therapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 57-75. ISBN 978-1-890504-68-7.

TERAPIA-ALVO; TERAPIA DO CANCER; HISTORIA TERAPIAS-ALVO; EVOLUCAO DE TERAPIAS-ALVO; ALVO RECEPTORES DA SUPERFICIE CELULAR; PAPEL DO ENFERMEIRO DE ONCOLOGIA EM TERAPIA-ALVO; PACIENTE E EDUCACAO FAMILIAR

234/399US=1 / Quimioterapia
Camp MJ, Gilmore JW, Gullatte MM, Hutcherson DA. Antineoplastic agents. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 77-362. ISBN 978-1-890504-68-7.

PRINCIPIOS EM QUIMIOTERAPIA; GENTES ANTINEOPLASICOS (A-Z)

235/399US=1 / Quimioterapia
Liewer S. Chemotherapy regimens. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 363-425. ISBN 978-1-890504-68-7.

REGIMES DE QUIMIOTERAPIA; ADENOCARCINOMA DE ORIGEM DESCONHECIDA; AIDS. CANCERES RELACIONADOS; TUMORES CEREBRAIS; CANCER DE MAMA; CANCER COLORRETAL

236/399US=1 / Quimioterapia
Gubili J, Cassileth B. Botanical and drug interactions in oncology. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 427-62. ISBN 978-1-890504-68-7.

BOTANICO E INTERACOES MEDICAMENTOSAS EM ONCOLOGIA; DONG QUAI; ECHINACEA; ALHO; GINKGO; GINSENG; CHA VERDE; CASTANHA; FLOR DA PAIXAO; TREVO VERMELHO; ERVA DE SAO JOAO; SAW PALMETTO; SELENIO; SOJA

237/399US=1 / Quimioterapia
Decker GM. Complementary and alternative medicine therapy: and overview. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 463-89. ISBN 978-1-890504-68-7.

TERAPIA COMPLEMENTAR; MEDICINA ALTERNATIVA; MEDICINA; TERAPIA

238/399US=1 / Quimioterapia
Brohard-Holbert C. Maximizing outpatient chemotherapy reimbursement. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 491-511. ISBN 978-1-890504-68-7.

QUIMIOTERAPIA AMBULATORIAL; CRONOLOGIA HISTORICA; CENTROS HOSPITALARES DE AMBULATORIAIS; USO OFF-LABEL DE MEDICAMENTOS; REESTRUTURACAO DE UM SISTEMA DE FATURAMENTO

239/399US=1 / Quimioterapia
Krumm S, Garrett MR. Legal issues in chemotherapy administration. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 513-26. ISBN 978-1-890504-68-7.

ADMINISTRACAO DE QUIMIOTERAPIA; RESPONSABILIDADE DE ENFERMAGEM

240/399US=1 / Quimioterapia
Cusack G. Vascular access devices. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 527-70. ISBN 978-1-890504-68-7.

DISPOSITIVOS DE ACESSO VASCULAR; TERAPIA DE INFUSAO; ACESSO VASCULARES CENTRAL; DISPOSITIVOS VASCULARES; CATETER VENOSO CENTRAL; CATETER CENTRAL DE INSERCAO; CATETERES INTRAVENTRICULARES; BOMBAS DE INFUSAO

Primeira | Anterior | Próxima | Última